Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 78.27
-3.27 (-4.01%)
Sep 24, 2026, 1:38 PM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 772.06 million as of September 24, 2026. Its market cap has increased by 56.69% in one year.
Market Cap
772.06M
Enterprise Value
464.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
78.27
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 772.06M, an increase of 1,347.56%. That is a compound annual growth rate of 60.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 772.06M | -10.22% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 757.93M |
| Satellos Bioscience | 258.20M |
| Eastwood Bio-Medical Canada | 126.06M |
| Helix BioPharma | 84.02M |
| ME Therapeutics Holdings | 60.78M |
| NurExone Biologic | 59.77M |
| BriaCell Therapeutics | 52.37M |
| MedMira | 45.61M |